Opportunity Information: Apply for PA 12 275
Apply for PA 12 275
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Examination of Survivorship Care Planning Efficacy and Impact R01" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.399 Cancer Control.
- This funding opportunity was created on Aug 29, 2012 and posted on Aug 29, 2012.
- Applicants must submit their applications by Jan 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments For profit organizations other than small businesses Independent school districts Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal organizations (other than Federally recognized tribal governments) State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments County governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The National Institutes of Health (NIH) funding opportunity PA-12-275, titled "Examination of Survivorship Care Planning Efficacy and Impact (R01)," was a discretionary grant program designed to build stronger evidence around survivorship care planning for people who have completed cancer treatment. The core focus was on understanding whether, how, and under what conditions survivorship care plans and related care-planning approaches actually improve outcomes for cancer survivors, not just in theory but in measurable, real-world practice. In practical terms, NIH was looking for rigorous research that could clarify what care planning should include, how it should be delivered, and how its value should be assessed across clinical, psychosocial, and health system dimensions.
A central aim of the announcement was to push the field beyond simply producing survivorship care plans and toward testing their effectiveness. The FOA emphasized research that develops and validates clear metrics for evaluating survivorship care planning, recognizing that progress depends on having reliable ways to measure what care planning changes for patients, providers, and health systems. Projects were encouraged to create and test evaluation tools and outcome measures that can capture the impact of care planning on survivors experiences and downstream care, including both short-term and longer-term effects.
The opportunity also highlighted the need to evaluate survivorship care planning in relation to concrete survivor outcomes. NIH specifically called for studies examining effects on health and psychosocial outcomes, morbidity, and survivors ability to self-manage late and long-term effects of cancer and its treatment. Another key area was adherence: whether survivorship care planning improves follow-through with recommended surveillance and screening, as well as broader health behavior guidelines. The FOA further encouraged research on utilization of appropriate follow-up care, such as whether care planning helps survivors access the right services at the right time, avoid unnecessary care, or reduce gaps and fragmentation between oncology and primary care.
Beyond patient-level outcomes, the FOA placed clear emphasis on system and organizational factors. Applicants were encouraged to study how survivorship care planning is implemented in different settings and what organizational characteristics shape its success or failure, such as staffing models, workflow integration, communication pathways between oncology and primary care, and institutional capacity. Costs were explicitly included as an outcome of interest, reflecting a desire to understand the resources required to implement survivorship care planning and whether the approach produces value when considering workload, efficiency, and financial impact on clinics and health systems.
Another major theme was identifying effective models and processes of care that support high-quality survivorship care planning. This could include testing different delivery strategies (for example, who leads the care planning, when it is delivered, and how it is updated), different formats (paper, electronic, integrated EHR tools), and different coordination approaches (oncology-led, primary care-led, shared-care, or navigation-supported models). The FOA was ultimately oriented toward generating actionable evidence that could translate into better interventions and best practices for follow-up care for cancer survivors, rather than producing one-size-fits-all recommendations.
Administratively, this was an NIH R01 grant opportunity within the Cancer Control area (CFDA 93.399) and did not require cost sharing or matching. The announcement was originally posted on August 29, 2012, with an original and final closing date of January 7, 2016, and an archive date of February 7, 2016, meaning it is no longer open for applications. Eligibility was broad and included many types of U.S. organizations such as state and local governments, public and private institutions of higher education, nonprofits (including 501(c)(3) organizations), for-profit entities, small businesses, tribal governments and organizations, school districts, special districts, and public housing authorities, among others. The FOA also allowed applications from non-U.S. entities (foreign institutions), non-U.S. components of U.S. organizations, and foreign components as defined in NIH policy, signaling an openness to international research contributions where appropriate.
Overall, PA-12-275 was aimed at strengthening the scientific foundation for survivorship care planning by funding research that measures impact with better tools, tests whether care planning improves survivor and system outcomes, and clarifies which implementation models work best in real clinical environments. The long-term intent was to help the field move toward evidence-based, scalable survivorship follow-up practices that improve quality of life, health outcomes, coordination of care, and the efficient use of healthcare resources.
Frequently Asked Questions (FAQs)
What is NIH funding opportunity PA-12-275?
PA-12-275 was a National Institutes of Health (NIH) discretionary grant funding opportunity titled "Examination of Survivorship Care Planning Efficacy and Impact (R01)." It supported research focused on survivorship care planning for people who have completed cancer treatment, with an emphasis on measuring real-world effectiveness and impact.
What type of grant mechanism did PA-12-275 use?
This opportunity used the NIH R01 research project grant mechanism.
What was the main purpose of this funding opportunity?
The main purpose was to build stronger evidence about whether, how, and under what conditions survivorship care plans and related care-planning approaches improve outcomes for cancer survivors in measurable, real-world practice. The FOA aimed to move the field beyond simply producing care plans and toward testing their effectiveness.
What did NIH mean by "survivorship care planning" in this FOA?
Based on the FOA description provided, survivorship care planning refers to survivorship care plans and related care-planning approaches intended to support follow-up care after cancer treatment. The FOA focused on what care planning should include, how it should be delivered, and how its value should be assessed across clinical, psychosocial, and health system dimensions.
What kinds of research questions was NIH encouraging?
NIH was encouraging rigorous research to clarify what survivorship care planning should include, how it should be delivered, and how to evaluate whether it improves outcomes for survivors, providers, and health systems. A strong emphasis was placed on understanding effectiveness in real clinical environments rather than assuming benefit in theory.
Was the FOA focused on creating survivorship care plans or testing their impact?
The FOA emphasized testing impact. It specifically aimed to push the field beyond producing survivorship care plans and toward evaluating their effectiveness and outcomes using clear, validated metrics.
Why were metrics and measurement tools such a central part of PA-12-275?
The FOA highlighted that progress in survivorship care planning depends on having reliable ways to measure impact. Projects were encouraged to develop and validate metrics, evaluation tools, and outcome measures that capture what care planning changes for survivors, providers, and health systems, including short-term and longer-term effects.
What survivor outcomes were specifically of interest?
NIH called for studies examining effects on health and psychosocial outcomes, morbidity, and survivors' ability to self-manage late and long-term effects of cancer and its treatment.
Did the FOA encourage research related to adherence to follow-up recommendations?
Yes. The FOA encouraged studies on whether survivorship care planning improves adherence to recommended surveillance and screening and to broader health behavior guidelines.
Was healthcare utilization an area of interest?
Yes. NIH encouraged research on utilization of appropriate follow-up care, including whether care planning helps survivors access the right services at the right time, avoid unnecessary care, and reduce gaps and fragmentation between oncology and primary care.
Did the FOA address coordination between oncology and primary care?
Yes. The FOA emphasized studying communication pathways and coordination between oncology and primary care, and how care planning might reduce fragmentation and gaps in follow-up care.
What implementation and organizational factors did NIH want applicants to examine?
Applicants were encouraged to study how survivorship care planning is implemented in different settings and what organizational characteristics shape success or failure. Examples mentioned include staffing models, workflow integration, communication pathways between oncology and primary care, and institutional capacity.
Were costs and resource requirements part of the evaluation?
Yes. Costs were explicitly included as an outcome of interest. NIH sought research that helps quantify the resources required to implement survivorship care planning and whether it produces value in terms of workload, efficiency, and financial impact on clinics and health systems.
What kinds of survivorship care planning models could be studied under this FOA?
The FOA highlighted identifying effective models and processes that support high-quality survivorship care planning. This could include testing who leads care planning, when it is delivered, how it is updated, and how care is coordinated.
Did the FOA support comparing different delivery strategies?
Yes. The FOA encouraged testing different delivery strategies, such as who leads the care planning, when it is delivered, and how it is updated over time.
Did the FOA mention different formats for survivorship care plans?
Yes. It referenced potential formats such as paper-based plans, electronic versions, and integrated electronic health record (EHR) tools.
What care coordination approaches were within scope?
The FOA indicated interest in multiple coordination approaches, including oncology-led, primary care-led, shared-care, and navigation-supported models.
Was this funding opportunity looking for one-size-fits-all recommendations?
No. The FOA was oriented toward generating actionable evidence and identifying what works best in real clinical environments, rather than producing one-size-fits-all recommendations.
What program area and CFDA number were associated with this opportunity?
This was an NIH opportunity within the Cancer Control area and was associated with CFDA 93.399.
Was cost sharing or matching required?
No. The opportunity did not require cost sharing or matching.
Is PA-12-275 currently open for applications?
No. The FOA is no longer open. It had an original and final closing date of January 7, 2016, and an archive date of February 7, 2016.
When was the FOA originally posted?
The announcement was originally posted on August 29, 2012.
Who was eligible to apply?
Eligibility was broad and included many types of U.S. organizations. Examples listed include state and local governments, public and private institutions of higher education, nonprofits (including 501(c)(3) organizations), for-profit entities, small businesses, tribal governments and organizations, school districts, special districts, and public housing authorities, among others.
Were non-U.S. (foreign) organizations eligible?
Yes. The FOA allowed applications from non-U.S. entities (foreign institutions), non-U.S. components of U.S. organizations, and foreign components as defined in NIH policy.
What was the long-term intent behind funding this research?
The long-term intent was to strengthen the scientific foundation for survivorship care planning and support evidence-based, scalable survivorship follow-up practices that improve quality of life, health outcomes, coordination of care, and efficient use of healthcare resources.
What kind of evidence was NIH ultimately trying to generate?
NIH was aiming for actionable evidence about impact and implementation: better measurement tools, clearer outcome data on survivors and systems, and practical insights on which survivorship care planning models work best in routine clinical practice.
Browse more opportunities from the same category: Education Health
Next opportunity: BLM OR WA Conservation and Habitat Restoration Projects
Previous opportunity: Examination of Survivorship Care Planning Efficacy and Impact R21
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 12 275
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 12 275) also looked into and applied for these:
| Funding Opportunity |
|---|
| FY 2013 American Schools and Hospitals Abroad Program Apply for DRAFT APS ASHA 12 000001 Funding Number: DRAFT APS ASHA 12 000001 Agency: Agency for International Development Category: Education Health Funding Amount: $2,000,000 |
| HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R21) Apply for PA 12 280 Funding Number: PA 12 280 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R01) Apply for PA 12 281 Funding Number: PA 12 281 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| AIDS Science Track Award for Research Transition (R03) Apply for PA 12 282 Funding Number: PA 12 282 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Revisions for Early Stage Development of Informatics Technology (R01) Apply for PAR 12 286 Funding Number: PAR 12 286 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Advanced Development of Informatics Technology (U24) Apply for PAR 12 287 Funding Number: PAR 12 287 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Early Stage Development of Informatics Technology (U01) Apply for PAR 12 288 Funding Number: PAR 12 288 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Revisions for Early Stage Development of Informatics Technology (U01) Apply for PAR 12 289 Funding Number: PAR 12 289 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revisions for Early Stage Development of Informatics Technology (P01) Apply for PAR 12 290 Funding Number: PAR 12 290 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Research Answers to NCIs Provocative Questions Group A (R01) Apply for RFA CA 12 015 Funding Number: RFA CA 12 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group A (R21) Apply for RFA CA 12 016 Funding Number: RFA CA 12 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group B (R01) Apply for RFA CA 12 017 Funding Number: RFA CA 12 017 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group B (R21) Apply for RFA CA 12 018 Funding Number: RFA CA 12 018 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group C (R01) Apply for RFA CA 12 019 Funding Number: RFA CA 12 019 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group C (R21) Apply for RFA CA 12 020 Funding Number: RFA CA 12 020 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group D (R01) Apply for RFA CA 12 021 Funding Number: RFA CA 12 021 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group D (R21) Apply for RFA CA 12 022 Funding Number: RFA CA 12 022 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50) Apply for PAR 12 296 Funding Number: PAR 12 296 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R01) Apply for PA 12 293 Funding Number: PA 12 293 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R03) Apply for PA 12 294 Funding Number: PA 12 294 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 12 275", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.